British pharmacy chain announces roll-out of new smart pills loaded with microchip
January 18, 2012
by Bob Yirka
in Medications
(Medical Xpress) -- A new pharmaceutical program that many Britons might find literally hard to swallow, has been announced. Pharmacy chain Lloydspharmacy has partnered with American technology firm Proteus Biomedical to bring to the British public a product called Helius; a tiny microchip that is swallowed in pill form and whose purpose is to help remind patients to take their medications on time and to offer bio-feedback such as body temperature, heart rate and even sleeping patterns.
The microchip, which becomes active when subjected to water, can be either embedded directly in regular medication pills, or placed in a placebo meant only to deliver the pill to the stomach in conjunction with regular medication. In either case, the microchip, or "ingestible event marker" (IEM) as Proteus calls it, is powered by a thin film non-toxic battery. Once activated, the IEM sends a tiny uniquely modulated high frequency electrical signal throughout the body, using the body as a conduit, thus, no radio frequency is used. Instead, a patch is applied to the skin on the outside of the body to listen for bodily interactions with the electrical signal, allowing for measurement of the heart-beat rate, internal body temperature, respiration rate, posture and sleeping patterns. All of this information is relayed via Smartphone app to a web site that provides statistics in graph form. Thus, patients can simply check their chart to see if they have taken all of their pills or not. The information could also be sent to the doctor who prescribed the medication to see if it’s having the desired effect.
This video is not supported by your browser at this time.
The whole idea is get patients to take all of their medications when they are supposed to be taken, which is a serious problem. The World Health Organization recently announced that it believes that as many as half the people in the world don’t take their medications correctly, putting themselves at risk.What’s not clear is how long the microchip operates inside the body, and what happens to it once it dies. Is it digested, or is it flushed out into the sewer system wholly intact? And if it’s flushed, what happens to all those millions of chips that wind up in sewage treatment facilities?
Such questions appear to be beside the point at this juncture, as the real issue is whether people will buy into the new technology, and if they do, if it will help them take their mediation properly. On the one hand, it might help people live better or longer. On the other, it appears that such pill takers would have to wear the patch that reads the data all the time and would have to have their Smartphones near at hand constantly as well. There’s also likely to be privacy issues as patients would have to rely on promises made by corporations that may or may not be securing their medical histories as well as patients would expect.
© 2011 PhysOrg.com
-
Chip-in-a-pill may be approved in 2012
Nov 10, 2010 |
not rated yet |
0
-
Rx for health: Engineers design pill that signals it has been swallowed
Mar 31, 2010 |
not rated yet |
0
-
Integrating medication regimens into daily routines can improve adherence
Sep 19, 2011 |
not rated yet |
0
-
MIT student builds self-balancing electric unicycle
Dec 29, 2011 |
not rated yet |
0
-
Mercedes demos DICE -- Interactive dashboard and Heads-Up display
Jan 17, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
May 23, 2013 |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
May 23, 2013 |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Medications
May 22, 2013 |
not rated yet |
0
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Pollen count apps for smartphones are nothing to sneeze at
Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.
Jan 18, 2012
Rank: not rated yet
Jan 18, 2012
Rank: 5 / 5 (2)
As opposed to carrying one around in your pocket all day?
Jan 19, 2012
Rank: not rated yet
and then they come out with this.
who is seriously going to use this?i can not think of a single person who would willingly use this.
or is this going to be their excuse for not giving their staff a rise this year?
oh, sorry. lost money on this thing.